Corpus Intelligence IC Memo — SSH - BOARDMAN INC 2026-04-26 12:05 UTC
IC Memo — SSH - BOARDMAN INC
Investment Committee Memorandum | OH | 79 beds | Grade C | EBITDA uplift $500K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - BOARDMAN INC

CCN 362023 | MAHONING, OH | 79 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSH - BOARDMAN INC is a 79-bed under-performing / distressed in MAHONING, OH with $6.7M in net patient revenue and a -21.7% operating margin. The hospital serves a payer mix of 46.1% Medicare, 6.3% Medicaid, and 47.6% commercial.

Thesis: Turnaround. Our ML models identify $500K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.7% to -14.2% (+751bps).

Net Revenue HCRIS$6.7M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-21.7%
Occupancy HCRIS36.2%
Revenue / Bed COMPUTED$84K
Net-to-Gross HCRIS13.7%
Distress Probability ML52.4%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
97
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -21.7% places it below the state median. Among 97 size-comparable peers (40-158 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-158), prioritizing same-state peers. 97 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - BOARDMAN INC (Target)OH79$6.7M-21.7%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
BLANCHARD VALLEY REG. HEALTH COH152$310.1M22.8%
SOIN MEDICAL CENTEROH120$256.3M-1.3%
LIMA MEMORIAL HOSPITALOH110$253.5M6.4%
UH AHUJA MEDICAL CENTEROH153$249.4M3.3%
FIRELANDS REGIONAL MEDICAL CENOH146$238.4M-13.9%
UH REGIONAL HOSPITALSOH144$214.6M-21.6%
UH ST. JOHN MEDICAL CENTEROH126$210.9M6.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $500K (751bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$140K+210bp18mo
Denial Rate Reduction12.0%6.5%$136K+205bp12mo
Cost to Collect4.5%2.5%$133K+200bp12mo
A/R Days Reduction5200.0%3800.0%$81K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$140K
Denial Rate Reduction
$136K
Cost to Collect
$133K
A/R Days Reduction
$81K
Clean Claim Rate
$10K
Total EBITDA Uplift$500K
Current EBITDA$-1.4M
+ RCM Uplift+$500K
Pro Forma EBITDA$-944K
Current Margin-21.7%
Pro Forma Margin-14.2%
WC Released (1x)$255K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.2M$-4.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.2M$-5.7M0.00x-100.0%
Bull Case9.0x11.0x$-2.0M$-4.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.0M$-5.8M0.00x-100.0%
Bear Case11.0x10.0x$-2.4M$-6.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.4M$-7.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 52.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 97 hospitals with 40-158 beds
  • Same-state prioritization (n=98)
  • Comp margins: P25=-10.5% / P50=2.8% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.